Riskpilot← Back to searchSign inGet full accessBioNordic A/S
A/SActiveCVR 40831622Automatikvej 1Manufacture of pharmaceutical preparations · NACE 2120Est. 20193 employeesbio-nordic.com
Revenue 2024
DKK 59,2M
-38% vs 2023
EBITDA margin
40.9%
-57% vs 2023
Equity ratio
7.9%
Financial strength
Net profit 2024
DKK -20,9M
-185% vs 2023
| Revenue | DKK 59,2M | -38% |
| EBITDA | DKK 24,2M | -57% |
| Net profit | DKK -20,9M | -185% |
| Total assets | DKK 394,9M | -5% |
| Equity | DKK 31M | -37% |
| Employees | 3 | — |
Legal name
BioNordic A/S
CVR number
40831622
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
23. september 2019
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening
Company purpose
Selskabets formål er at drive handel og industri samt efter bestyrelsens beslutning udøve enhver virksomhed i forbindelse hermed.
Address
Automatikvej 1
Phone
+4520946876
Email
stefan.michelsen@bio-nordic.com
Website
bio-nordic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 201.237 | 40.332 | 77.810 | 95.559 | 59.212 |
| Staff expenses | -20.225 | -24.630 | -35.502 | -38.586 | -34.894 |
| EBITDA | 37.224 | 14.846 | 28.588 | 56.930 | 24.213 |
| Depreciation & amort. | -10.170 | -21.571 | -9.561 | -13.367 | -11.099 |
| EBIT | 27.054 | -6.725 | 19.027 | 43.562 | 13.114 |
| Net financials | -1.481 | 11.779 | -7.731 | -9.658 | -21.428 |
| Profit before tax | 25.573 | 5.053 | 11.296 | 33.904 | -8.314 |
| Tax | 9.098 | 4.645 | 6.140 | 9.355 | 12.547 |
| Net profit | 16.475 | 408 | 5.157 | 24.549 | -20.860 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 199.440 | 252.629 | 394.101 | 413.922 | 394.857 |
| Equity | 17.087 | 18.211 | 24.828 | 48.871 | 31.025 |
| Long-term debt | 134.180 | 118.920 | 139.210 | 200.954 | 196.220 |
| Short-term debt | 48.172 | 106.580 | 216.824 | 163.183 | 166.698 |
| Total debt | 182.352 | 225.499 | 356.035 | 364.137 | 362.918 |
EBITDA margin
40.9%
This company
15.8%
Market median
+159% vs market
20202024
Equity ratio
7.9%
This company
38.2%
Market median
-79% vs market
20202024
Return on equity
-67.2%
This company
18.4%
Market median
-465% vs market
20202024
Net profit margin
-35.2%
This company
8.1%
Market median
-535% vs market
20202024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20202024
Debt / equity
11.73×
This company
0.62×
Market median
-1792% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-09-23 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TZ Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
HB Unofficial title | Unofficial title | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2021 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2022 | |
| Individual | 25.0% | 25.0% | 2022 | |
| Individual | 25.0% | 25.0% | 2022 | |
| Individual | 10.0% | 10.0% | 2022 | |
| Individual | 10.0% | 10.0% | 2022 | |
| Individual | 5.0% | 5.0% | 2022 | |
| Individual | 10.0% | 10.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BioNordic A/S 
NeXXerum ApSBoard members of BioNordic A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Troels Zakarias Glahn Kristiansen | Chief Executive Officer | 0 companies |
| Henrik Bernt Sanders | Unofficial title | 0 companies |
| Jørn Martin Bank | Deputy Chairman | 0 companies |
| Lene Ploug Bülow | Board of Directors | 0 companies |